ICI 35-868 |
DISOPRIVAN |
PROPOFOL |
DISOPROFOL |
NSC-5105 |
RAPINOVET |
ICI-35868 |
ICI35,868 |
DIPRIVAN |
ICI 35868 |
DIPRIVAN® |
2,6-DIISOPROPYLPHENOL |
PROPOFOLUM |
2,6-BIS(1-METHYLETHYL)PHENOL |
drugbank:00818 |
pubchem.compound:4943 |
rxcui:8782 |
chemidplus:2078-54-8 |
chembl:CHEMBL526 |
Year of Approval | 1989 |
Drug Class | hypnotics and sedatives |
FDA Approval | approved |
Drug Class | small molecule |
Drug Indications | sedative |
positive modulator (activating) |
potentiator |
Trial Name | propofol lingual spray |
Novel drug target | Established target |
Trial Name | propofol,Diprivan |
positive modulator (activating) |
potentiator |
Trial Name | propofol,Diprivan |
Novel drug target | Established target |
Trial Name | propofol lingual spray |
inhibitor (inhibitory) |
Trial Name | propofol lingual spray |
Novel drug target | Established target |
Trial Name | propofol,Diprivan |
inhibitor (inhibitory) |
Trial Name | propofol lingual spray |
Novel drug target | Established target |
Trial Name | propofol,Diprivan |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
PROPOFOL | Primary Drug Name |
Drug Class | hypnotics and sedatives |
Year of Approval | 1989 |
Drug Indications | sedative |
Drug Class | small molecule |
FDA Approval | approved |
C29384 | NCI drug code |
D0A3HB | TTD Drug ID |